Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis

SinnoVex is a drug from the group of bioanalogues of interferon beta-1a for intramuscular administration, which has moderate efficacy in reducing clinical exacerbations of multiple sclerosis (MS), which is most pronounced in the initial treatment of relapsing-remitting MS (RRMS) with low or moderate...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Неврология, нейропсихиатрия, психосоматика
المؤلفون الرئيسيون:	F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin
التنسيق:	مقال
اللغة:	الروسية
منشور في:	IMA-PRESS LLC 2024-08-01
الموضوعات:	multiple sclerosis relapsing-remitting multiple sclerosis multiple sclerosis disease-modifying treatments interferon beta-1a
الوصول للمادة أونلاين:	https://nnp.ima-press.net/nnp/article/view/2312